Boyd Watterson Asset Management LLC OH Increases Stock Holdings in Waters Corporation $WAT

Boyd Watterson Asset Management LLC OH boosted its stake in Waters Corporation (NYSE:WAT) by 1,381.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,371 shares of the medical instruments supplier’s stock after acquiring an additional 2,211 shares during the period. Boyd Watterson Asset Management LLC OH’s holdings in Waters were worth $706,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Turtle Creek Wealth Advisors LLC bought a new stake in shares of Waters during the 1st quarter valued at about $237,000. New York State Teachers Retirement System grew its holdings in shares of Waters by 57.2% during the 1st quarter. New York State Teachers Retirement System now owns 76,471 shares of the medical instruments supplier’s stock worth $22,773,000 after acquiring an additional 27,815 shares during the period. Private Advisor Group LLC grew its holdings in shares of Waters by 29.7% during the 1st quarter. Private Advisor Group LLC now owns 7,602 shares of the medical instruments supplier’s stock worth $2,264,000 after acquiring an additional 1,740 shares during the period. Y Intercept Hong Kong Ltd raised its position in shares of Waters by 271.5% in the 1st quarter. Y Intercept Hong Kong Ltd now owns 9,938 shares of the medical instruments supplier’s stock worth $2,960,000 after acquiring an additional 7,263 shares in the last quarter. Finally, Leonteq Securities AG raised its position in shares of Waters by 144.3% in the 1st quarter. Leonteq Securities AG now owns 469 shares of the medical instruments supplier’s stock worth $140,000 after acquiring an additional 277 shares in the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Stock Performance

Waters stock opened at $378.62 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $37.18 billion, a P/E ratio of 48.11, a PEG ratio of 2.29 and a beta of 1.20. The stock’s 50 day moving average is $350.65 and its 200 day moving average is $346.80. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the business earned $2.25 earnings per share. The firm’s quarterly revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, equities research analysts predict that Waters Corporation will post 14.51 earnings per share for the current fiscal year.

Analyst Ratings Changes

WAT has been the topic of several research reports. UBS Group lifted their price target on Waters from $330.00 to $375.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. The Goldman Sachs Group upgraded Waters to a “strong-buy” rating in a report on Wednesday, April 1st. Wolfe Research started coverage on Waters in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $425.00 price objective for the company. Sanford C. Bernstein assumed coverage on shares of Waters in a report on Friday, June 26th. They set an “outperform” rating and a $435.00 target price on the stock. Finally, Evercore raised shares of Waters from an “in-line” rating to an “outperform” rating and set a $350.00 target price on the stock in a research report on Monday, April 6th. Four investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $396.68.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.